Evidence map›Paper›PMID 41249114›Full record

ArticleCell death & disease2025

C8orf33 dictates DNA double-strand break repair choice by modulating KAT8-mediated H4K16 acetylation.

Laila A Bishara, Enas R Abu-Zhayia, Marian Nicola, Nabieh Ayoub

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laila A BisharaDepartment of Biology, Technion - Israel Institute of Technology, Haifa, 3200003, Israel.
Enas R Abu-ZhayiaDepartment of Biology, Technion - Israel Institute of Technology, Haifa, 3200003, Israel.
Marian NicolaDepartment of Biology, Technion - Israel Institute of Technology, Haifa, 3200003, Israel.
Nabieh AyoubDepartment of Biology, Technion - Israel Institute of Technology, Haifa, 3200003, Israel. ayoubn@technion.ac.il.ORCID http://orcid.org/0000-0002-9549-9929

Funding

Israel Cancer Research Fund (Israel Cancer Research Fund, Inc.) 22-110-PGIsrael Science Foundation (ISF) 2511_2019 and 1962_2024
6 · The paper itself

Abstract

Homologous recombination (HR) and non-homologous end joining (NHEJ) are two main repair pathways of DNA double-strand breaks (DSBs). The regulation of repair pathway choice is crucial for maintaining genomic stability and preventing carcinogenesis. Consequently, there is increasing interest in elucidating the molecular mechanisms that govern DSB repair pathway selection. Here, we identify chromosome 8 open reading frame 33 (C8orf33) as a novel regulator of DSB repair choice. We show that C8orf33 is a nuclear protein localized predominantly to the nucleolus and is recruited to DSB sites within both nuclear and nucleolar regions. We demonstrate that C8orf33 promotes the recruitment of 53BP1, thus channeling DSB repair toward NHEJ. Consequently, C8orf33 inhibits DNA end resection and counteracts the recruitment of HR factors, BRCA1 and RAD51, to DSB sites. Mechanistically, chromatin profiling analysis reveals that C8orf33 antagonizes the chromatin association of KAT8 acetyltransferase at DSB sites leading to reduced histone 4 lysine 16 acetylation (H4K16ac) levels. Accordingly, the loss of C8orf33 enhances KAT8 chromatin binding that increases H4K16ac levels. This promotes the recruitment of HR factors while suppressing the accumulation of NHEJ factors at DSB sites, thereby favoring HR over NHEJ. Additionally, we demonstrate that the elevated HR activity in C8orf33-deficient cells causes genomic instability, as evidenced by accelerated loss of ribosomal DNA repeats and increases cell death. Collectively, our findings establish C8orf33 as a critical regulator of DSB repair pathway choice, safeguarding genomic integrity.

Indexed as

DNA Breaks, Double-StrandedDNA End-Joining RepairDNA RepairHistone AcetyltransferasesHistonesNuclear ProteinsAcetylationBRCA1 ProteinChromatinGenomic InstabilityHeLa CellsHumansRad51 RecombinaseTumor Suppressor p53-Binding Protein 1BRCA1 ProteinChromatinHistone AcetyltransferasesHistonesNuclear ProteinsRad51 RecombinaseTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID41249114
PMCPMC12624059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.